Page last updated: 2024-08-22

camptothecin and cbp-93872

camptothecin has been researched along with cbp-93872 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, Y; Harada, N; Makishima, F; Nakanishi, K; Nakanishi, M; Sakumoto, H; Tsuchiya, M; Watanabe, Y; Yoshimura, Y1

Other Studies

1 other study(ies) available for camptothecin and cbp-93872

ArticleYear
Identification of a checkpoint modulator with synthetic lethality to p53 mutants.
    Anti-cancer drugs, 2011, Volume: 22, Issue:10

    Topics: Aniline Compounds; Antineoplastic Agents; Camptothecin; CDC2 Protein Kinase; Cell Proliferation; Checkpoint Kinase 1; Cyclin B; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; G1 Phase; G2 Phase; High-Throughput Screening Assays; HT29 Cells; Humans; Mutation; Phosphorylation; Propanolamines; Protein Kinases; Reproducibility of Results; Tumor Suppressor Protein p53

2011